Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Hims & Hers Health Inc (NY: HIMS ) 23.75 -0.62 (-2.54%) Official Closing Price Updated: 7:00 PM EDT, Jun 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Hims & Hers Health Inc < Previous 1 2 3 4 5 Next > 3 Sector Stars Lead Growth: Foot Locker, Shake Shack, Hims & Hers June 10, 2024 These three stocks are looking to get a chunk of the total added jobs in the economy, meaning that analyst double-digit upside and growth projections are real Via MarketBeat Topics Economy Exposures Economy MarketBeat Week in Review – 6/3 - 6/7 June 08, 2024 Equity markets shrugged off a much hotter-than-expected jobs report, but there could be more volatility after the next readings on inflation come out next week Via MarketBeat Topics Economy Exposures Interest Rates Hims & Hers Health Soars on Generic GLP-1 Rollout Plans June 03, 2024 Him & Hers Health Inc. (NYSE: HIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatments Via MarketBeat Hims & Hers Health Inc. (NYSE: HIMS) Near the Top of Equities by Percentage Gain on 2/27 February 27, 2024 Via Investor Brand Network Call Option Volumes Spiked For These 3 Stocks May 30, 2024 Option traders decided to plow into call contracts for these three stocks, investors can see the specific fundamental reasons behind this decision Via MarketBeat LifeMD Can Surge on Its GLP-1 Offerings May 28, 2024 LifeMD is a leading telehealth provider that investors should take note of; the company is entering the GLP-1 market, and its stock could soar as a result Via MarketBeat Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers May 20, 2024 From Hims & Hers Via Business Wire Hims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to its Board of Directors May 16, 2024 From Hims & Hers Via Business Wire 3 Stocks That Suddenly Drew in Options Traders May 13, 2024 Three discounted stocks caught the attention of call option buyers last week, and they have Wall Street analysts to back them through double-digit upside. Via MarketBeat Hims & Hers Health Stock Could Become a Wealth Compounder May 07, 2024 Hims & Hers stock could give investors the best of both stability and double-digit upside through EPS projections and price targets, especially after 1Q24 Via MarketBeat Topics Economy Exposures Economy Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results May 06, 2024 From Hims & Hers Health, Inc. Via Business Wire Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024 April 15, 2024 From Hims & Hers Health, Inc. Via Business Wire Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member April 04, 2024 From Hims & Hers Health, Inc. Via Business Wire 3 Stocks With Unusual Call Option Activity March 26, 2024 Three stocks reported rising call option buying activity could see even higher prices soon. Analysts see the writing on the wall, and traders stampeded in Via MarketBeat Topics Economy Exposures Interest Rates LifeMD Shares Come Back to Life on GLP-1 Business Growth March 19, 2024 LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024 Via MarketBeat Can WeightWatchers Regain its Mojo after Oprah Steps Down? March 13, 2024 WW International Inc. (NASDAQ: WW) (WeightWatchers) has had a disastrous 2024, with its shares collapsing 66.7% year-to-date (YTD). Via MarketBeat Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024 March 11, 2024 From Hims & Hers Health, Inc. Via Business Wire Hims & Hers Stock Rises On Stimulating Earnings Growth March 05, 2024 Telehealth platform Hims & Hers has turned the corner into GAAP profitability and is expanding its product portfolio to increase its addressable audience Via MarketBeat bluebird bio stock is ripe for a 400% institutional short squeeze February 27, 2024 Bluebird Bio stock could be on the verge of a 400% pop on earnings, management has set the writing on the wall for institutional buying to trickle in Via MarketBeat Topics Economy Exposures Interest Rates Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results February 26, 2024 From Hims & Hers Health, Inc. Via Business Wire This healthcare stock making a buzz with 160% growth February 26, 2024 Healthcare stocks are typically on the boring side of the spectrum, that is until you add a bit of technology and the right niche to them. Via MarketBeat Topics Economy Exposures Economy Hims & Hers Names Dan Kenger as the Company’s First Chief Design Officer February 20, 2024 From Hims & Hers Health, Inc. Via Business Wire Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024 February 05, 2024 From Hims & Hers Health, Inc. Via Business Wire Hims & Hers Teams with Hartford HealthCare to Connect People to In-person Care January 11, 2024 From Hims & Hers Health, Inc. Via Business Wire Weight Watchers gains from Oprah’s GLP-1 weight-loss January 02, 2024 Oprah Winfrey revealed she has lost over 60 pounds and is on the path to reaching her weight goal of 167 lbs. She credits this to taking GLP-1 medication Via MarketBeat Topics Artificial Intelligence Exposures Artificial Intelligence LifeMD expands telehealth GLP-1weight-loss service with Medifast December 19, 2023 LifeMD Inc. (NASDAQ: LFMD) is a direct-to-consumer (DTC) comprehensive virtual healthcare platform. The company offers per-visit and membership plan pricing Via MarketBeat Ozempic vs. Mounjaro:: Battle of the bulge December 04, 2023 The year 2023 was a breakout year for glucagon-like peptide (GLP-1) weight-loss drugs, led by the popularity of Ozempic. Celebrity usage Via MarketBeat Exposures Product Safety Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss December 04, 2023 From Hims & Hers Health, Inc. Via Business Wire Hims & Hers earnings highlight expanded personalized treatments November 29, 2023 E-health and wellness platform operator Hims & Hers Inc. reported a stellar quarter of growth that highlighted its expanded line of personalized products Via MarketBeat Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook November 06, 2023 From Hims & Hers Health, Inc. Via Business Wire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.